WHO Releases Statement on the antigen composition of COVID-19 vaccines
On Dec. 18, 2025, the World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) announced…
CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Influenza | Measles | Vaccine
Harsh Flu Season May Be Driven by New Variant K
On Dec. 16, 2025, researchers from the International Vaccines Access Center (IVAC) reported that as of mid-December, flu,…
Flu, RSV activity rising in US and Europe, with major UK surge in flu cases
On Dec. 12, 2025, the Center for Infectious Disease Research & Policy (CIDRAP) reported COVID-19 rates in the…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Medical Device | Nanotechnology
new antibody test only takes 10 minutes, no blood draw necessary
On Nov. 20, 2025, an interdisciplinary research team at the University of Pittsburgh has developed wearable biosensors that…
Biotechnology | CDC | COVID-19 | Infectious Disease | Measles | Vaccine
Canada Loses Measles Elimination status after three decades
On Nov. 10, 2025, Canada has lost its measles elimination status after nearly three decades due to its…
Women are three times more likely than men to get severe long COVID
On Nov. 7, 2025, research published today in Cell Reports Medicine reveals key biological differences that may explain why…
Study finds no link between mRNA COVID vaccines early in pregnancy and birth defects
On Oct. 15, 2025, mRNA COVID-19 vaccination in the first trimester of pregnancy isn’t tied to an elevated…
Biotechnology | CDC | COVID-19 | Diagnostics | Genomics | Infectious Disease | Measles | NIH | Polio | Vaccine | Women's Health
CDPH and West Coast Health Alliance Release Statement Responding to ACIP Updates to National Vaccine Recommendations
On Sept. 19, 2025, the state health officials of the members of the West Coast Health Alliance, including…
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH | Vaccine
Kennedy’s vaccine advisers change COVID shot guidance, calling them an individual choice
On Sept. 19, 2025, Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers added confusion to this fall’s…
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
On Sept. 8, 2025, Pfizer and BioNTech announced positive topline results from an ongoing Phase 3 clinical trial…
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH | Vaccine | Women's Health
Washington State Department of Health confirms COVID-19 vaccine position with Standing Order
On Sept. 5, 2025, The Washington State of Health (DOH) issued a Standing Order for the COVID-19 vaccine,…
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | NIH | Vaccine | Women's Health
Hawaii to join West Coast Health Alliance with California, Oregon, and Washington
On Sept. 4, 2025, roughly 24 hours after the launch of the West Coast Health Alliance, Hawaii is…
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
On Sept. 4, 2025, Novavax announced a milestone payment from Takeda has been triggered by regulatory approval for Novavax’s…
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | NIH | Vaccine | Women's Health
California, Oregon, and Washington to launch new West Coast Health Alliance to uphold scientific integrity in public health as Trump destroys CDC’s credibility
On Sept. 3, 2025, California Governor Gavin Newsom, Oregon Governor Tina Kotek, and Washington Governor Bob Ferguson announced…
CDC | COVID-19 | Infectious Disease | Influenza | Measles | NIH | Non-Profit Research | U.S. Congress | Vaccine | Women's Health
U.S. CDC chief exits after weeks in role, three top officials resign
On Aug. 27, 2025, the U.S. Centers for Disease Control and Prevention (CDC) Director Susan Monarez has left…
Novavax’s Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
On Aug. 27, 2025, Novavax announced that the U.S. Food and Drug Administration (FDA) has approved the Nuvaxovid™ 2025-2026…
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64
On Aug. 27, 2025, Pfizer and BioNTech announced the U.S. Food and Drug Administration (FDA) has approved the…
Researchers identify a potential biomarker for long COVID
On Aug. 11, 2025, Researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, and…
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
U.S. abandons mRNA vaccine development despite triumphs
On Aug. 8, 2025, the U.S.Department of Health and Human Services (HHS) announced that it was winding down…
Novel immunologic surveillance study provides new insights into post-pandemic return of respiratory viruses
On Aug. 7, 2025, The first paper from a multi-year clinical research study has been published in The…
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
On Jul. 25, 2025, Pfizer and BioNTech announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products…
Wastewater Measures of SARS-CoV-2 Accurately Predict Frequency of Symptomatic Infections in the Community
On Jul. 24, 2025, a University of Minnesota study shows that widespread immunity through vaccination or natural infection…
Agriculture | Artificial Intelligence | Biotechnology | COVID-19 | CRISPR | Diagnostics | Genomics | Infectious Disease | Materials | Medical Device | Stem Cell | Therapeutics | Vaccine
China approving innovative drugs at record pace as discovery momentum shifts from the West
On Jul. 24, 2025, The China Times reported that China is making inroads in the race for innovative…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
On Jul. 22, 2025, AstraZeneca announces $50 billion of investment in the United States by 2030, building on…
Biotechnology | COVID-19 | Diagnostics | Genomics | HIV | Infectious Disease | Influenza | Measles | Non-Profit Research | Plague | Polio | Therapeutics | Vaccine
Huge biosecurity centre investment to boost UK pandemic protection
On Jul. 17, 2025, a new world-leading biosecurity centre in Essex has been announced that will protect the…
Biotechnology | COVID-19 | HIV | Infectious Disease | Influenza | Measles | Plague | Polio | Vaccine
Global childhood vaccination coverage holds steady, yet over 14 million infants remain unvaccinated
On Jul. 15, 2025, in 2024, 89% of infants globally – about 115 million – received at least…
Biotechnology | COVID-19 | Diagnostics | HIV | Infectious Disease | Influenza | Measles | NIH | Vaccine
Emergency vaccine response has cut infectious disease deaths by nearly 60% since 2000
On Jul. 14, 2025, researchers at Burnet Institute, in collaboration with Gavi, the Vaccine Alliance, have provided the…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Measles | NIH | Plague | Vaccine
NIH suspends dozens of pathogen studies over ‘gain-of-function’ concerns
On Jul. 11, 2025, in response to White House concerns about allegedly risky research on viruses, bacteria, and…
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease
On Jul. 10, 2025, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental…
Cognitive impairment Found 2 years after mild to severe SARS-CoV-2 infection
On Jul. 8, 2025, a study published in Nature showed the prevalence of cognitive impairment 2 years after…